Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)

The Canadian product safety information for lorazepam and midazolam warn that they should not be used during pregnancy. The Canadian product safety information for phenobarbital warns that during pregnancy the drug’s benefit should be weighed against its risk. Also, restrictions for use in children vary from one drug to another.

Publisher - Current Organization Name: Health Canada
Licence: Open Government Licence - Canada

Data and Resources

Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)HTML
English publication HTML
Explore
- More information
- Go to resource
Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)HTML
French publication HTML
Explore
- More information
- Go to resource

Similar records